The Diabetic Foot: Deciding on Amputation Level

Immediate management priorities:

1. Sepsis control: The patient is febrile with cellulitis and osteomyelitis. Obtain blood cultures and deep wound cultures before antibiotics. Start broad-spectrum IV antibiotics (e.g., piperacillin-tazobactam or vancomycin + ceftazidime) covering gram-positive, gram-negative, and anaerobes. Adjust based on culture results and renal function (eGFR 45).
2. Glycemic control: Optimize insulin therapy to maintain blood glucose 140-180 mg/dL. Poor control impairs healing and increases infection risk.
3. Wound care: Offload the foot (total contact cast or wheelchair), regular debridement of necrotic tissue, and dressing changes.
4. Vascular assessment: The ABI of 0.6 indicates moderate PAD. Revascularization (angioplasty or bypass) is essential for healing if the foot is salvageable. Consult vascular surgery urgently. Assess with duplex ultrasound or CT angiography to plan revascularization.
5. Surgical debridement: Urgent surgical debridement of infected and necrotic tissue, including resection of the infected metatarsal head if osteomyelitis is confirmed. This may be done as a limb-sparing procedure.

Factors determining choice:

• Extent of infection and bone involvement: Localized osteomyelitis of the first metatarsal head can be managed with resection of the metatarsal head (ray amputation) if the rest of the foot is viable.
• Vascular status: If revascularization is feasible and successful, limb salvage is more likely. If not, amputation may be necessary.
• Functional status and patient preference: The patient is reluctant to amputation; explore his goals and expectations. A multidisciplinary team (vascular, orthopedic, podiatric, infectious disease) should discuss options.
• Renal function: Affects antibiotic dosing and contrast for angiography; consider CO2 angiography or MR angiography if contrast is a concern.
• Soft tissue coverage: After debridement, plastic surgery may be needed for flap coverage.
• Amputation level: If amputation is required, aim for the most distal level that will heal. A below-knee amputation may be needed if the foot is non-viable, but a ray amputation or transmetatarsal amputation could be considered if vascular supply is adequate.

Next steps in management:

• Assess for residual infection: Ensure osteomyelitis is eradicated. Repeat imaging (MRI or X-ray) and consider bone biopsy if there is any doubt. Continue antibiotics for a total of 6-8 weeks for osteomyelitis (duration depends on culture and clinical response).
• Wound bed preparation: The wound is granulating, which is positive. Exposed bone without periosteum may not support a skin graft. Options include:
  • Negative pressure wound therapy (NPWT): Apply NPWT to promote granulation tissue over the bone. NPWT can be used over exposed bone, but careful monitoring is needed. It helps reduce edema, increase blood flow, and stimulate granulation.
  • Bone debridement: If the bone is necrotic, further debridement may be needed until healthy bleeding bone is reached.
  • Skin grafting: Once the wound bed is covered with healthy granulation tissue, a split-thickness skin graft can be applied. If bone remains exposed, a flap may be required (e.g., local muscle flap or free flap).
  • Offloading: Continue offloading to protect the graft and promote healing.
• Multidisciplinary follow-up: Podiatry, vascular, plastic surgery, and infectious disease.
• Patient education: Foot care, glycemic control, and adherence to offloading.

Role of NPWT: NPWT is useful for complex wounds with exposed bone or tendon, but it should not be used if there is active infection or malignancy. It can be a bridge to grafting or definitive closure. Skin grafting should be delayed until the wound is free of infection and has a healthy granulating bed. If the bone is exposed, a flap may be necessary instead of a skin graft.